|
U.S. health and agriculture officials have allocated nearly $200 million to address a bird flu outbreak affecting dairy cows in nine states, with over 40 herds affected. The funding includes $101 million for prevention, testing, and treatment efforts, and about $98 million to support individual farms in testing cattle and enhancing biosecurity measures. Dairy farmers will receive compensation for milk production losses, and incentives are provided for farm workers to participate in testing and workplace studies, aiming to mitigate reluctance among farmers and workers.
|
The US Food and Drug Administration (FDA) is contemplating a mandate for blood banks to adopt a new test capable of detecting malaria parasites in donors' blood, seeking input from its independent advisers on strategies to prevent transfusion-related malaria cases while ensuring blood donation accessibility. Although malaria isn't considered a significant threat to the US blood supply, approximately 28 million US residents travel annually to malaria-endemic regions worldwide, with concerns rising due to increasing travel and climate change potentially facilitating malaria spread within the US. The FDA recently approved the Cobas malaria test, capable of detecting malaria RNA and DNA in donor blood, acknowledging the potential severity of transfusion-transmitted malaria infections, which can be fatal.
|
A cyberattack on the Ascension health system, affecting 140 hospitals across 19 states in the US, led to ambulance diversions, delays in medical tests, and disrupted online access to patient records. While Ascension acknowledged "unusual activity" on its network, it refrained from confirming whether the attack involved ransomware or if any ransom was paid, engaging Mandiant, a leading cybersecurity responder, for assistance. The incident, exhibiting ransomware characteristics, prompted precautionary measures such as disconnecting electronic medical record systems to contain the spread.
|
A recent survey by KFF reveals that approximately 1 in 8 adults in the United States have used GLP-1 drugs such as Ozempic or Mounjaro, with around 6% of adults currently prescribed these medications, totaling over 15 million individuals. The demand for these drugs has surged, leading to shortages reported by the US Food and Drug Administration, particularly for Ozempic, Wegovy, and Mounjaro, as manufacturers struggle to keep pace. While most adults use GLP-1 drugs to manage chronic conditions like diabetes or heart disease, about 40% of respondents admit to using them solely for weight loss.
|
The U.S. government has implemented new regulations regarding the importation of dogs from other countries, aimed at preventing the spread of rabies. Effective August 1, these rules mandate that all dogs entering the country must be at least 6 months old, microchipped for rabies vaccination verification, and have completed a new CDC import form. These requirements apply to dogs brought in by breeders, rescue groups, or traveling with their U.S. owners. Additional restrictions and prerequisites may apply based on the dog's location in the previous six months, potentially including blood testing from CDC-approved labs. The regulations aim to address the evolving landscape of international pet travel, with approximately 1 million dogs entering the U.S. annually.
|
|